Skip to main content
KUKJEON PHARMACEUTICAL Co.,Ltd logo

KUKJEON PHARMACEUTICAL Co.,Ltd — Investor Relations & Filings

Ticker · 307750 ISIN · KR7307750000 KO Manufacturing
Open in API
Filings indexed 320 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 307750

About KUKJEON PHARMACEUTICAL Co.,Ltd

https://www.kukjeon.co.kr/en/

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company's portfolio includes raw materials for specialized medicines such as choline alfoscerates, benfothiamines, and napamostat. A key product is Itopride hydrochloride, a functional indigestion treatment, for which the company holds a proprietary manufacturing patent. In addition to its pharmaceutical focus, the company also develops and supplies chemical materials for the electronics industry.

Recent filings

Filing Released Lang Actions
소속부변경
Regulatory Filings
2026-04-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a “주식등의 대량보유상황보고서” (Large Shareholding Status Report) filed under Korea’s Capital Markets Act, detailing a major shareholder’s holdings, threshold crossings, related contracts, and beneficiary information. This is not an earnings release or management discussion but a notification of significant changes in share ownership levels. Accordingly, it fits the definition of a Major Shareholding Notification.
2026-04-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a formal report titled “주식등의 대량보유상황보고서(일반)” under the Korean Capital Markets Act, detailing large shareholding (>5%) by 홍종호 and related parties, including share counts, ratios, changes, and contract details. It is clearly a major shareholding notification rather than an earnings release, AGM material, or management commentary. Therefore, it matches the “Major Shareholding Notification” category (Code: MRQ).
2026-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal announcement of the resolutions and vote outcomes from the company’s regular shareholders’ meeting, showing approval of financial statements, election of board members, amendments to the articles of association, vote percentages, and related details. This corresponds exactly to “Declaration of Voting Results & Voting Rights Announcements.”
2026-03-31 Korean
상호변경안내
Regulatory Filings Classification · 1% confidence The document is a formal disclosure about a corporate name change (“상호변경안내”) decided at the shareholders’ meeting on 2026-03-31, with before/after names and related links. It is not reporting financial results, a share issuance, or board changes, nor is it a proxy or dividend notice. It is a standard regulatory announcement for administrative corporate changes. This falls under the fallback category for general regulatory filings (RNS).
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a statutory notification to the Financial Supervisory Service/Korea Exchange regarding the appointment, reappointment, dismissal, and retirement of outside directors. There are no financial statements or earnings figures, no reference to shareholder votes or dividends, and no mention of a broader investor presentation. It specifically details board composition changes, placing it in the Board/Management Information category.
2026-03-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.